News

• Delivery Hero jumps 8% on S. Korea deal approval
  12/28/2020 / 11:45 - TeleTrader
•  
• Satsuma Pharmaceuticals to Participate in the Evercore ISI 3rd Annual HealthCONx Conference 
  11/24/2020 / 22:16 - GlobeNewswire
•  
• Satsuma Pharmaceuticals Provides Business Update and Reports Third Quarter 2020 Financial Results
  11/10/2020 / 22:02 - GlobeNewswire
•  
• Satsuma Pharmaceuticals to to participate in the following November Virtual Investor Conferences
  11/02/2020 / 22:34 - GlobeNewswire
•  
• Satsuma Pharmaceuticals Announces Topline Results from EMERGE Phase 3 Trial of STS101 for the Acute Treatment of Migraine
  09/10/2020 / 14:00 - GlobeNewswire
•  
• Satsuma Pharmaceuticals to Participate in September Virtual Investor Conferences
  09/04/2020 / 00:57 - GlobeNewswire
•  
• Newcore Gold Announces Start of Drill Program at its 100% Owned Enchi Gold Project, Ghana
  08/12/2020 / 13:00 - GlobeNewswire
•  
• Satsuma Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
  08/12/2020 / 07:55 - GlobeNewswire
•  
• Satsuma Pharmaceuticals Announces Enrollment of First Patient in the ASCEND™ Phase 3 open-label, safety trial of STS101
  08/06/2020 / 22:01 - GlobeNewswire
•  
• Satsuma Pharmaceuticals to Present Two Posters at the American Headache Society’s Annual Scientific Meeting Hosted via a Virtual Meeting Platform
  06/11/2020 / 22:05 - GlobeNewswire
•  
• Satsuma Completes Enrollment in Pivotal Phase 3 EMERGE trial of STS101 for Acute Treatment of Migraine
  06/01/2020 / 22:05 - GlobeNewswire
•  
• Satsuma Pharmaceuticals to To Present at the Jefferies Virtual Healthcare Conference
  05/27/2020 / 14:30 - GlobeNewswire
•  
• Satsuma Pharmaceuticals Announces Poster Presentations on the American Academy of Neurology 2020 Science Highlights Virtual Platform
  05/18/2020 / 22:05 - GlobeNewswire
•  
• Satsuma Pharmaceuticals Reports First Quarter 2020 Financial and Business Results
  05/12/2020 / 22:01 - GlobeNewswire
•  
• Satsuma Pharmaceuticals to Host Key Opinion Leader Event: STS101 and the Acute Treatment of Migraine
  04/28/2020 / 22:05 - GlobeNewswire